Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Lower IQ In Children Linked To Pre-Birth Air Pollution Exposure, Study
Research conducted in New York City found that children exposed to urban air pollution before birth were more likely to have a lower IQ than
generic viagra online
Liver Transplantation After Drug Induced Acute Liver Failure Examined By Study
Liver transplantation offers a good chance for survival for patients with drug induced acute liver failure, however, certain pre-transplant factors are associated with worse outcomes. Patients who are on life support, who have elevated serum creatinine, and children whose liver failure was caused by antiepileptic drugs did not fare as well after transplantation. These findings are in the July issue of Liver Transplantation, a journal published by John Wiley & Sons. The article is also available online at Wiley Interscience.
News of the day
DaVita Study Demonstrates Clinical Application Of Sysmex Reticulocyte Hemoglobin Equivalent (RET-He) Parameter
Sysmex America, Inc. announced that a study titled "Day-to-Day, Week-to-Week, and Day-of-the-Week Variations in Tests of Anemia and Iron Status in Hemodialysis Patients" has identified Sysmex"s Reticulocyte Hemoglobin Equivalent (RET-He) parameter result as key input used by physicians to assist in Anemia treatment decisions in ESRD patients on hemodialysis. David Van Wyck, M.D., Vice President of Clinical Affairs at DaVita Inc., and Emeritus Professor of Medicine and Surgery at the University of Arizona College of Medicine, in Tucson et. al followed five hematologic parameters in 30 patients undergoing hemodialysis three times a week. The patients were followed for 12 consecutive treatment days. The parameters studied were Hb, Hct, reticulocyte Hb (RET He or CHr), TSAT and ferritin levels.
Sexual Health

Singer Elton John Calls For Increased HIV/AIDS Education, Care

Singer Elton John on Tuesday at the 2009 Bio International Convention in Atlanta called for renewed efforts to fight HIV/AIDS, the Atlanta Journal-Constitution reports. John, founder of the Elton John AIDS Foundation, addressed an audience that included CEOs of organizations working to develop HIV/AIDS therapies and vaccines. He called on governments and institutions to increase their focus on education, especially among young people; access to medical treatment; and needle-exchange programs (Poole, Atlanta Journal-Constitution, 5/19)."There are long-standing stereotypes and prejudices that inhibit our efforts to combat AIDS," John said, adding, "I am asking for your leadership." According to John, CDC estimates that one in every three new HIV cases occurs among people younger than age 30, a statistic that he said has not received adequate attention. "It is unfathomable and unconscionable that we are not making a bigger effort to educate this demographic about HIV/AIDS with creative materials and up-to-date information," John said, adding, "Our failure to do so is costing lives" (Turner, AP/PennLive.com, 5/19). John also noted a recent report by the Kaiser Family Foundation, which found that the number of Americans who believe HIV/AIDS is an urgent health problem has declined to 6% currently from 44% in 1995. Bob McNally, CEO of GeoVax Labs, said John"s message is that "just not enough is being done" and that "people continue to die from the disease." He added that John "spurred the audience towards being advocates" (Atlanta Journal-Constitution, 5/20). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009